HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yun Li Selected Research

allyl isothiocyanate

11/2013Enhanced inhibition of urinary bladder cancer growth and muscle invasion by allyl isothiocyanate and celecoxib in combination.
2/2012The principal urinary metabolite of allyl isothiocyanate, N-acetyl-S-(N-allylthiocarbamoyl)cysteine, inhibits the growth and muscle invasion of bladder cancer.
9/2011Allyl isothiocyanate arrests cancer cells in mitosis, and mitotic arrest in turn leads to apoptosis via Bcl-2 protein phosphorylation.
12/2010Allyl isothiocyanate-rich mustard seed powder inhibits bladder cancer growth and muscle invasion.
2/2010Inhibition of bladder cancer development by allyl isothiocyanate.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yun Li Research Topics

Disease

141Neoplasms (Cancer)
06/2022 - 12/2004
57Infections
07/2022 - 11/2004
44Inflammation (Inflammations)
05/2022 - 06/2008
39Breast Neoplasms (Breast Cancer)
01/2022 - 02/2004
28Neoplasm Metastasis (Metastasis)
10/2022 - 11/2002
27Hypertension (High Blood Pressure)
01/2022 - 05/2006
25Hypoxia (Hypoxemia)
08/2021 - 01/2005
21Stroke (Strokes)
02/2022 - 12/2010
21Lung Neoplasms (Lung Cancer)
12/2021 - 04/2005
18Asthma (Bronchial Asthma)
08/2021 - 07/2006
17Cardiovascular Diseases (Cardiovascular Disease)
10/2022 - 05/2010
15Body Weight (Weight, Body)
01/2022 - 11/2007
15Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 12/2011
14Hepatocellular Carcinoma (Hepatoma)
10/2022 - 01/2015
14Atherosclerosis
01/2022 - 07/2009
14Bacterial Infections (Bacterial Infection)
01/2021 - 02/2010
14Insulin Resistance
01/2021 - 09/2006
14Carcinogenesis
01/2020 - 01/2013
13Prostatic Neoplasms (Prostate Cancer)
01/2022 - 09/2008
13Obesity
01/2022 - 05/2012
13Ischemic Stroke
01/2021 - 03/2013
12Type 2 Diabetes Mellitus (MODY)
01/2020 - 10/2005
12Ischemia
01/2019 - 09/2003
11COVID-19
11/2022 - 01/2020
11Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
06/2022 - 04/2012
11Pain (Aches)
03/2022 - 10/2007
11Alzheimer Disease (Alzheimer's Disease)
01/2022 - 05/2011
11Wounds and Injuries (Trauma)
01/2022 - 08/2010
11Virus Diseases (Viral Diseases)
01/2022 - 02/2005
10Carcinoma (Carcinomatosis)
08/2022 - 12/2004
10Rheumatoid Arthritis
01/2022 - 05/2009
10Cognitive Dysfunction
01/2022 - 03/2010
10Reperfusion Injury
01/2021 - 04/2010
9Necrosis
01/2022 - 04/2005
9Anemia
08/2020 - 02/2011
9Essential Hypertension
11/2015 - 07/2005
8Chronic Obstructive Pulmonary Disease (COPD)
10/2021 - 03/2008
7Brain Ischemia (Cerebral Ischemia)
06/2022 - 08/2013
7Weight Gain
03/2022 - 07/2013
7Sepsis (Septicemia)
01/2022 - 03/2015
7Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022 - 03/2009
7Non-alcoholic Fatty Liver Disease
01/2022 - 01/2018
7Epilepsy (Aura)
01/2022 - 12/2017
7Sleep Initiation and Maintenance Disorders (Insomnia)
01/2022 - 08/2013
7Stomach Neoplasms (Stomach Cancer)
01/2022 - 05/2012
7Coronary Disease (Coronary Heart Disease)
12/2021 - 07/2009
7Starvation
08/2021 - 03/2009
7Hemorrhage
03/2021 - 04/2012
7Frailty
01/2021 - 01/2018
7Myocardial Infarction
12/2020 - 04/2005
6Urinary Bladder Neoplasms (Bladder Cancer)
02/2022 - 02/2010
6Tuberculosis (Tuberculoses)
01/2022 - 01/2014
6Squamous Cell Carcinoma of Head and Neck
01/2022 - 08/2008

Drug/Important Bio-Agent (IBA)

73Proteins (Proteins, Gene)FDA Link
06/2022 - 12/2004
44Biomarkers (Surrogate Marker)IBA
03/2022 - 08/2008
30CytokinesIBA
05/2022 - 03/2008
26Messenger RNA (mRNA)IBA
01/2021 - 12/2004
24Oxygen (Dioxygen)IBA
01/2022 - 09/2003
24MicroRNAs (MicroRNA)IBA
01/2022 - 01/2013
23Glucose (Dextrose)FDA LinkGeneric
01/2022 - 09/2006
22Pharmaceutical PreparationsIBA
05/2022 - 10/2008
20RNA (Ribonucleic Acid)IBA
06/2022 - 11/2010
19Biological ProductsIBA
03/2022 - 08/2010
16Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 06/2011
14EnzymesIBA
01/2021 - 06/2008
13LipidsIBA
04/2022 - 02/2008
13Peptides (Polypeptides)IBA
01/2022 - 12/2007
13Interleukin-6 (Interleukin 6)IBA
01/2022 - 11/2007
13C-Reactive ProteinIBA
01/2022 - 07/2009
12Long Noncoding RNAIBA
01/2022 - 01/2019
11Insulin (Novolin)FDA Link
02/2022 - 09/2006
11Transcription Factors (Transcription Factor)IBA
01/2022 - 01/2005
10AntigensIBA
03/2022 - 07/2006
10Antiviral Agents (Antivirals)IBA
01/2022 - 06/2008
10Therapeutic UsesIBA
10/2021 - 11/2008
9Hemoglobins (Hemoglobin)IBA
10/2022 - 02/2011
9DNA (Deoxyribonucleic Acid)IBA
05/2022 - 04/2009
9CholesterolIBA
01/2022 - 12/2010
9CateninsIBA
01/2022 - 01/2016
9Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 12/2010
9Caspase 3 (Caspase-3)IBA
01/2021 - 01/2005
8LigandsIBA
06/2022 - 06/2008
8Phosphotransferases (Kinase)IBA
06/2022 - 01/2016
8Fatty Acids (Saturated Fatty Acids)IBA
01/2022 - 01/2015
8Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2018 - 11/2007
7VaccinesIBA
10/2022 - 05/2009
7ErbB Receptors (EGF Receptor)IBA
06/2022 - 06/2013
7Interleukin-10 (Interleukin 10)IBA
01/2022 - 06/2008
7IronIBA
08/2020 - 10/2013
6AntibodiesIBA
11/2022 - 01/2011
6InterferonsIBA
05/2022 - 04/2002

Therapy/Procedure

69Therapeutics
12/2022 - 04/2005
15Drug Therapy (Chemotherapy)
01/2021 - 04/2005
11Transplantation
01/2022 - 04/2011
10Radiotherapy
01/2021 - 03/2007
9Renal Dialysis (Hemodialysis)
01/2019 - 05/2012
7Thoracotomy
09/2013 - 11/2002
6Length of Stay
03/2022 - 10/2015
6Immunotherapy
02/2022 - 12/2007
6Continuous Positive Airway Pressure
01/2022 - 01/2014